Problems in pharmacoeconomic analyses
- PMID: 11035880
Problems in pharmacoeconomic analyses
Comment on
-
Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme.JAMA. 2000 Apr 26;283(16):2116-21. doi: 10.1001/jama.283.16.2116. JAMA. 2000. PMID: 10791503
Similar articles
-
Can pharmacoeconomic guidelines be implemented successfully in Asia?J Med Econ. 2008;11(2):341-3. doi: 10.3111/13696990802221171. J Med Econ. 2008. PMID: 19450090 No abstract available.
-
[Educational standards of the Polish Pharmacoeconomic Society].Pol Merkur Lekarski. 2009 Nov;27(161):400-3. Pol Merkur Lekarski. 2009. PMID: 19999805 Polish.
-
Evaluating the quality of published pharmacoeconomic evaluations.Hosp Pharm. 1995 Feb;30(2):146-8, 151-2. Hosp Pharm. 1995. PMID: 10140528 No abstract available.
-
A comparative review of pharmacoeconomic guidelines.Pharmacoeconomics. 1995 Sep;8(3):182-9. doi: 10.2165/00019053-199508030-00002. Pharmacoeconomics. 1995. PMID: 10155616 Review.
-
Application of pharmacoeconomics to formulary decision making in managed care organizations.Am J Manag Care. 2002 Feb;8(2):161-9. Am J Manag Care. 2002. PMID: 11858228 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources